<?xml version="1.0" encoding="UTF-8"?>
<xml>
 <records>
  <record>
   <ref-type name="Journal Article">17</ref-type>
   <contributors>
    <authors>
     <author></author>
     <author></author>
     <author></author>
     <author></author>
    </authors>
   </contributors>
   <titles>
    <title></title>
   </titles>
   <dates>
    <year>2021</year>
    <pub-dates>
     <date>2021-06-30</date>
    </pub-dates>
   </dates>
   <doi>10.1007/s11094-021-02402-3</doi>
   <abstract>A new method for the synthesis of glycyrrhizic acid (GA) conjugates with S-benzyl-L-cysteine using 1-ethyl-3-(3-dimethylaminoproopyl)carbodiimide is proposed. It is established that 3-O-{2-O-[N-(beta-D-glucopyranosyluronyl)-L-cysteine-S-benzyl]-N-(beta-D-glucopyranosyluronyl)-L-cysteine-S-benzyl}-(3 beta,20 beta)-11-oxo-30-(N-carbonyl-L-cysteine-S-benzyl)-30-norolean-12-ene is superior to GA in inhibiting the accumulation of HIV-I virus-specific protein p24 (viral antigen) in MT-4 cell culture (IC50 3 mu g/mL, SI 90) and is 50 - 55 times less toxic to cells than azidothymidine.</abstract>
   <urls>
    <web-urls>
     <url>https://repo.bashgmu.ru/publication/2029</url>
    </web-urls>
    <pdf-urls>
     <url>https://repo.bashgmu.ru/files/2201</url>
    </pdf-urls>
   </urls>
  </record>
 </records>
</xml>
